
Shoulder Innovations rose 46.7% from $13.84 to $20.31, ahead of the S&P 500's +9.7%. Its worst day was Aug 7 (−8.2%), and its low came Feb 11 at $12.25.
Nov 20, 2025 – Nov 19, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Shoulder Innovations shares rose 13.5%, while the S&P 500 fell 0.3%.
+13.5% · S&P 500 −0.3%
Shoulder Innovations closed at its lowest level of the year, 11.5% below where the year started.
−7.1% · S&P 500 0.0%
Story events cover the past 12 months · Times ET
EPS of $-0.38 beat the $-0.42 estimate on $14.4M revenue (est. $12.7M); FY revenue guidance of $62.0M–$65.0M against the $59.1M consensus.
+7.4% · S&P 500 −0.1%
EPS of $-0.41 beat the $-0.44 estimate on $16.7M revenue (est. $14.3M); FY revenue guidance of $65.0M–$68.0M against the $63.9M consensus.
+15.2% · S&P 500 +0.8%
Shoulder Innovations shares rose 16.8%, while the S&P 500 fell 1.6%.
+16.8%, the year's best day · S&P 500 −1.6%
Shoulder Innovations shares rose 11.0%, while the S&P 500 fell 0.8%.
+11.0% · S&P 500 −0.8%
Shoulder Innovations closed at its highest level of the year, 75.2% above where the year started.
+15.7% · S&P 500 +0.2%
EPS of $-0.49 missed the $-0.46 estimate on $17.2M revenue (est. $16.9M); FY revenue guidance of $67.0M–$69.0M against the $67.1M consensus.
−8.2%, the year's worst day · S&P 500 +0.6%
Shoulder Innovations shares rose 10.1%, while the S&P 500 rose 0.2%.
+10.1% · S&P 500 +0.2%
EPS of $-0.34 beat the $-0.49 estimate on $16.2M revenue (est. $16.4M); FY revenue guidance of $67.0M–$69.0M against the $68.0M consensus.
+0.8% · S&P 500 +0.3%
Where it ended: a close of $20.31 on Nov 19, 2026. Up next: Q4 2026 earnings on Mar 9, 2027 (EPS est. $-0.47, revenue est. $18.7M).
Nothing in the past 12 months.
All SI dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SI and SPY from Benzinga historical bars. Not investment advice.